- JP-listed companies
- SHOEI YAKUHIN CO.,LTD.
SHOEI YAKUHIN CO.,LTD. (3537) Stock Price
Price and Volume
Market Cap
PER
PBR
Business Overview
Shoei Pharmaceutical primarily operates in the chemicals business, handling oleochemicals—chemical products derived from natural oils and fats. Oleochemicals are produced from raw materials such as palm oil and coconut oil, and are characterized by their renewability and low environmental impact.
In its chemicals business, Shoei Pharmaceutical procures oleochemicals including fatty acids, fatty amines, fatty alcohols, and glycerin as raw materials for surfactants, and sells these to intermediate product manufacturers. The final products are used in soaps, detergents, shampoos, cosmetics, and similar consumer goods.
In its consumer products business, Shoei Pharmaceutical develops household detergents and industrial cleaning agents under the theme of "safety and reliability," and sells them through OEM arrangements. Leveraging its expertise in the chemicals business, the company efficiently sources optimal raw materials and outsources production.
In its civil engineering and construction materials business, Shoei Pharmaceutical handles materials and additives used for ground improvement and concrete repair. Particularly in the sale of environmental remediation agents, the company holds patent rights and maintains competitive advantages. Through these strengths, it collaborates with general contractors in developing new construction methods.
Management Policy
Shoei Pharmaceutical pursues sustainable growth through a "concentration strategy" focused on deepening market penetration across its three business divisions: chemicals, consumer products, and civil engineering materials. The company concentrates management resources particularly in the chemicals sector, centered on oleochemicals, to achieve efficient market expansion.
Under its medium-term management plan, Shoei Pharmaceutical targets sustained increases in gross profit. For the fiscal year ending March 2026, the company projects net sales of 24,464 million yen and gross profit of 2,016 million yen, aiming for stable growth while adapting to changes in the economic environment.
Shoei Pharmaceutical's chemicals business handles oleochemicals as raw materials for surfactants and has built a business model covering the entire distribution chain from upstream to downstream. This supports new product development tailored to customer needs and drives global business expansion.
In the consumer products business, the company strengthens product planning centered on "safety and reliability" and conducts sales through OEM arrangements. Leveraging expertise from the chemicals business, it efficiently procures optimal raw materials and outsources production, aiming to deliver products that enhance customer brand value.
In the civil engineering materials business, the company focuses on selling materials and additives used for ground improvement and concrete repair. Particularly in environmental remediation products, it pursues differentiation through joint development with general contractors. This strengthens the foundation supporting sustainable growth.